Qualifest-T 1gm/0.125gm Injection
Marketer
Neiss Labs Pvt Ltd
Salt Composition
Ceftazidime (1gm) + Tazobactum (0.125gm)
Overview Qualifest-T 1gm/0.125gm Injection
Combiflex-B 1g/0.125g Injection is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism inhibits microbial proliferation, thus curbing infection spread. Administration must be strictly under a doctor's guidance; adherence to the prescribed schedule is crucial. Complete the full course of treatment, even with symptom improvement, as premature cessation can compromise efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening side effects immediately to your physician. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor of all current medications before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While it generally doesn't affect driving ability, refrain from driving if experiencing somnolence or dizziness. Adequate rest, a nutritious diet, and sufficient hydration are recommended for optimal recovery. Your doctor might order lab tests to monitor the drug's effects.
Primary Ingredients of Qualifest-T 1gm/0.125gm Injection
No text provided to rephrase.
Uses of Qualifest-T 1gm/0.125gm Injection
Infections caused by bacteria
Major Benefits of Qualifest-T 1gm/0.125gm Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Qualifest-T 1gm/0.125gm Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Qualifest-T 1gm/0.125gm Injection:
This medication will be administered by your healthcare provider. Self-medication is not recommended.
How Qualifest-T 1gm/0.125gm Injection works:
Qualifest-T 1gm/0.125gm Injection merges Ceftazidime, a potent antibiotic, with Tazobactum, a beta-lactamase inhibitor. Ceftazidime's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactum counteracts bacterial resistance mechanisms, thereby optimizing Ceftazidime's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Qualifest-T 1gm/0.125gm Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Qualifest-T (1gm/0.125gm) is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, clinical data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Qualifest-T 1gm/0.125gm Injection is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
Administration of Qualifest-T 1gm/0.125gm Injection may induce drowsiness, visual disturbances, or dizziness. Driving is prohibited should these effects manifest.
KidneyCAUTION
Patients with kidney impairment should use Qualifest-T 1gm/0.125gm Injection cautiously, as dose modification may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Qualifest-T 1gm/0.125gm Injection. Dosage modification of Qualifest-T 1gm/0.125gm Injection may be necessary. Physician consultation is recommended.
What if you forget to take Qualifest-T 1gm/0.125gm Injection :
Omit a Qualifest-T 1gm/0.125gm Injection dose? Seek your physician's advice.
Facts to Know About Qualifest-T 1gm/0.125gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Infectious Disease Treatments |
3,018 People bought this recently